John C. Jacobs, President, CEO at Harmony Biosciences Holdings, Inc. (HRMY), sold 57,400 shares at $45.17 ($2.6M) on 2022-01-03, disclosed to the SEC on 2022-01-05.
Open-market sale of $2.6M HRMY by President, CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.17 | 10,647 | $481K | 18.6% |
| 2 | $45.17 | 10,647 | $481K | 18.6% |
| 3 | $45.15 | 18,053 | $815K | 31.4% |
| 4 | $45.15 | 18,053 | $815K | 31.4% |
| Total | $45.16 avg | 57,400 | $2.6M | 100% |
| Filing → |
| HRMY | SELL | 2022-06-14 | $2.2M | — | Filing → |
| HRMY | SELL | 2022-03-18 | $680K | — | Filing → |
| HRMY | SELL | 2022-03-16 | $2.1M | — | Filing → |